EMMA
Emmaus Life Sciences, Inc.
-0.00 (-2.76%)0.06USD110K成交股數4.2M市值–本益比(近四季)0.3股價營收比+124.3%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 6.3M+163% | 2.0M-40% | 3.4M-38% | 2.8M-48% | 2.4M-4% | 3.3M-34% | 5.5M-49% | 5.4M-20% | 2.5M | 5.0M | 10.8M | 6.8M |
| 營業成本 | 344K | 168K | 247K | 150K | 225K | 309K | 394K | 241K | 257K | 214K | 508K | 429K |
| 毛利 | 6.0M+174% | 1.8M-39% | 3.1M-38% | 2.7M-48% | 2.2M-3% | 3.0M-38% | 5.1M-50% | 5.1M-19% | 2.2M | 4.8M | 10.3M | 6.3M |
| 毛利率 | 94.6% | 91.5% | 92.7% | 94.7% | 90.6% | 90.6% | 92.8% | 95.5% | 89.7% | 95.7% | 95.3% | 93.6% |
| 研發費用 | 116K | 40K | 50K | 56K | 176K | 137K | 146K | 191K | 183K | 414K | 320K | 289K |
| 銷售管理費用 | 1.6M | 1.9M | 1.7M | 2.3M | 2.3M | 2.3M | 2.8M | 2.7M | 2.9M | 2.9M | 4.1M | 4.9M |
| 營業利益 | 3.8M-487% | −823K+48% | 695K-15% | −370K-164% | −980K-64% | −557K-2421% | 821K-75% | 582K-150% | −2.7M | 24K | 3.3M | −1.2M |
| 營業利益率 | 60.0% | -41.5% | 20.6% | -13.1% | -40.7% | -16.9% | 15.0% | 10.8% | -109.3% | 0.5% | 30.9% | -17.3% |
| 稅後淨利 | 1.3M-157% | −3.3M+91% | −2.1M-214% | −1.1M-48% | −2.3M-46% | −1.7M-2709% | 1.8M-217% | −2.2M-37% | −4.3M | 67K | −1.6M | −3.5M |
| 淨利率 | 21.2% | -168.3% | -61.5% | -40.3% | -96.8% | -53.1% | 33.4% | -40.6% | -173.5% | 1.3% | -14.5% | -51.1% |
| 稀釋 EPS | 0.02-150% | -0.05+67% | -0.03-200% | -0.02-33% | -0.04-43% | -0.03+200% | 0.03-200% | -0.03-57% | -0.07 | -0.01 | -0.03 | -0.07 |
| 稀釋股數 | 121M | 70.2M | 63.9M | 63.9M | 63.9M | 63.2M | 63.9M | 63.4M | 61.8M | 138M | 52.9M | 50.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 2.8M | 1.1M | 293K | 886K | 1.3M | 1.4M | 1.3M | 1.5M | 1.7M | 1.5M | 1.4M | 1.8M |
| 應收帳款 | 709K | 2.0M | 2.6M | 2.1M | 2.1M | 2.6M | 4.9M | 4.6M | 3.0M | 4.6M | 5.6M | 2.2M |
| 存貨 | 1.6M | 1.9M | 1.2M | 1.3M | 1.4M | 1.6M | 1.6M | 1.6M | 1.5M | 1.7M | 1.8M | 2.2M |
| 總資產 | 16.4M | 18.7M | 20.8M | 23.3M | 22.5M | 23.6M | 27.3M | 25.9M | 29.5M | 47.5M | 50.3M | 48.9M |
| 有息負債 | 25.0M | 26.6M | 29.1M | 29.7M | 29.0M | 29.0M | 29.3M | 29.4M | 29.4M | 32.5M | 31.3M | 32.2M |
| 總負債 | 82.5M | 86.6M | 80.2M | 79.0M | 81.1M | 80.1M | 81.1M | 83.0M | 83.2M | 83.8M | 85.3M | 84.9M |
| 股東權益 | −66.2M | −67.9M | −59.5M | −55.7M | −58.6M | −56.5M | −53.8M | −57.0M | −53.6M | −36.3M | −35.0M | −37.4M |
| 負債比 | 504.3% | 463.0% | 386.6% | 338.6% | 360.7% | 339.3% | 296.7% | 319.8% | 281.6% | 176.6% | 169.7% | 173.5% |
| 淨現金(現金 − 有息負債) | −22.2M | −25.5M | −28.8M | −28.8M | −27.7M | −27.6M | −28.0M | −27.8M | −27.7M | −31.0M | −30.0M | −30.4M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −344K | – | – | 279K+99% | – | – | – | 140K | – | – | −1.3M |
| 資本支出 | – | – | – | – | – | – | – | – | 4K | – | – | 6K |
| 自由現金流 | – | – | – | – | – | – | – | – | 136K | – | – | −1.3M |
| 折舊攤銷 | – | 15K | – | – | 5K | – | – | – | 6K | – | – | 9K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | 5.4% | – | – | -19.2% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 12.5M
| Endari US | 9.0M | 72.7% | -32.9% |
|---|---|---|---|
| Endari International | 3.2M | 25.5% | +19.1% |
| Product And Service Other | 225K | 1.8% | -55.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 12.5M | -25.2% | −7.5M | -60.2% | -0.12 | −12K |
| FY2024 | 16.7M | -43.7% | −6.5M | -38.7% | -0.10 | −2.3M |
| FY2023 | 29.6M | +60.9% | −3.7M | -12.6% | -0.07 | −1.5M |
| FY2022 | 18.4M | -10.8% | −10.6M | -57.8% | -0.21 | −5.1M |
| FY2021 | 20.6M | -11.0% | −15.9M | -77.4% | -0.32 | −1.3M |
| FY2020 | 23.2M | +1.8% | 1.4M | 5.8% | 30.00 | −2.5M |
| FY2019 | 22.8M | +38.2% | −54.8M | -241.0% | -1.30 | −4.6M |
| FY2018 | 16.5M | – | −72.6M | -441.0% | -1.97 | −5.7M |